Total raised
$18.2M
Last: Series A 2024-02
Stage
Series A
Founded
2015
Headcount
9
HQ
—
Sector
Health Tech & Life Sciences
About
Vessi Medical is developing a new approach in the treatment of urological tissue. The company treats superficial urological tissue using surface cryotherapy, utilizing extreme cold to freeze and destroy abnormal tissue.
The Vessi Medical system consists of a stand-alone console and a disposable catheter which is inserted into the bladder in a manner similar to existing intravesical techniques. Vessi's minimally invasive unique cryotherapy solution provides a therapeutic alternative to surgery while reducing the cost and complications associated with current treatments.
First in human study (FIH) clinical trial was finalized (2023) , with very promising results.
Funding history · 2 rounds · $18.2M total
2024-02
Series A
$16.5M
2020-03
Seed
$1.7M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
catheterstargeted-therapyurologyhospitalsoncologycancermedical-devicesdoctorstreatmentsmedical-technologiesminimally-invasive